entertainment -WSS

entertainment

author：hotspot 2025-09-02 11:35:58 - browse：33

Zepbound, a injectable drug on a gradient background of dark purple and green — biotech coverage from STAT — Illustration: STAT; Source: Eli Lilly/AP

Eli Lilly’s blockbuster diabetes and obesity drug improved living scarring in a mid-stage study of the liver disease MASH, adding to positive data announced earlier this year.

The study tested three doses of tirzepatide, sold commercially as Mounjaro or Zepbound. The percentage of patients who experienced a greater than one-stage improvement in scarring, or fibrosis, without worsening of their disease was 54.9%, 51.3%, and 51.0% from the lowest to highest doses.

When compared with the 29.7% of patients on placebo who achieved this outcome, the results were statistically significant, according to an abstract of data that will be presented at the annual meeting of the European Association for the Study of the Liver.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： Fertility clinic egg and embryo storage is a disaster

focus

WSS

Pharma’s losing bet in New Jersey

WuXi Biologics beefs up its lobbying operation

Novo Nordisk testing Wegovy against alcohol

Medical students need to learn the potent medicine of empathy

Why H5N1 bird flu is keeping the CDC's top flu scientist awake

Novo Nordisk testing Wegovy against alcohol

Wikipedia

entertainment

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

hotspot

Continuity nursing helped my family in our darkest PICU moments

The world needs the new pandemic treaty

United colonoscopy coverage change 'may cost lives,' doctors say

Decentralized clinical trials need collaboration to achieve wider use

Guidelines to prevent youth baseball injuries need more muscle

Lawsuit challenges CMS nursing home minimum staffing rule

In age of alternative facts, a scholarly course on calling out crap

Louisiana bill approved classifying abortion pills as controlled substances

At least 13 dead in Texas as scorching temps continue

Richard Slayman had a rejection episode of his pig kidney before leaving hospital

focus

STAT reporters are Pulitzer Prize finalists for investigative reporting

Hottest summer in 2,000 years puts focus on extreme heat, health

Readout Newsletter: Biogen, Ionis, Johnson & Johnson news

Stroke rates rising, especially in working

Obesity drug from Roche shows promise in early study

Novo Nordisk testing Wegovy against alcohol

Wikipedia

focus

leisure time

entertainment